title: Recurrent thrombosis despite a therapeutic international normalised ratio.
authors.affiliation: School of Medicine, Manchester Royal Infirmary, UK.
authors.forename: Amy
authors.initials: A
authors.lastname: Carroll
authors.forename: Linda
authors.initials: L
authors.lastname: Griffiths
authors.forename: Vaikom
authors.initials: V
authors.lastname: Mahadevan
authors.forename: Jaspal
authors.initials: J
authors.lastname: Dua
authors.forename: Jecko
authors.initials: J
authors.lastname: Thachil
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D019343:Citric Acid / Q000008:administration & dosage*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D018729:Fontan Procedure / Q000009:adverse effects; D006330:Heart Defects, Congenital / Q000601:surgery; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D012008:Recurrence; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D019343:Citric Acid; D014859:Warfarin; D006493:Heparin